Colrain Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-4,000
Closed -$373K 82
2015
Q3
$373K Sell
4,000
-2,000
-33% -$193K 0.04% 78
2015
Q2
$585K Sell
6,000
-1,200
-17% -$120K 0.05% 78
2015
Q1
$724K Sell
7,200
-2,800
-28% -$285K 0.06% 74
2014
Q4
$1.05M Buy
10,000
+4,500
+82% +$474K 0.08% 72
2014
Q3
$586K Sell
5,500
-500
-8% -$51.9K 0.04% 79
2014
Q2
$628K Sell
6,000
-1,500
-20% -$152K 0.05% 82
2014
Q1
$737K Buy
7,500
+2,500
+50% +$232K 0.05% 78
2013
Q4
$458K Hold
5,000
0.03% 86
2013
Q3
$433K Sell
5,000
-2,500
-33% -$224K 0.03% 85
2013
Q2
$644K Buy
+7,500
New +$636K 0.05% 83

Other funds holding JNJ

Colrain Capital's JNJ Position: Q4 2015 in Review

Colrain Capital sold out of Johnson & Johnson (JNJ) in Q4 2015, closing a stake of 4,000 shares — an estimated $373K sold.

Colrain Capital first reported a position in JNJ in Q2 2013 and held it in 10 quarters. The position peaked at $1.05M in Q4 2014. 2,192 funds tracked by Wall St. Rank hold JNJ as of Q4 2015.

  • Colrain Capital reported no remaining Johnson & Johnson position as of Q4 2015 after selling out during the quarter.
  • Colrain Capital sold 4,000 Johnson & Johnson shares in Q4 2015, an estimated $373K.
  • Colrain Capital first reported a position in Johnson & Johnson in Q2 2013 and held it in 10 quarters.
  • Colrain Capital's Johnson & Johnson position peaked at $1.05M in Q4 2014.
  • 2,192 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2015.

Based on Colrain Capital's 13F filing for Q4 2015, filed 5 Feb 2016.